drugset / Press release
Emergent BioSolutions Joins Effort to Combat National Public Health Threat From Opioid Overdose Through Acquisition of Adapt Pharma and Its Flagship Product NARCAN® (naloxone HCl) Nasal Spray
2018-08-28 · Emergent BioSolutions · original emergentbiosolutions.com ↗
Download PDF 143.8 KB
The release as fetched from its publisher. emergentbiosolutions.com ↗